載入...
Evaluation of the efficacy and safety of vilazodone for treating major depressive disorder
PURPOSE: Vilazodone is a novel serotonin (5-HT)-reuptake inhibitor and 5-HT(1A) partial agonist that was recently developed for the treatment of major depressive disorder (MDD). We conducted a meta-analysis and systematic review to better evaluate the efficacy and safety of vilazodone. MATERIALS AND...
Na minha lista:
| 發表在: | Neuropsychiatr Dis Treat |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4531002/ https://ncbi.nlm.nih.gov/pubmed/26345981 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S87968 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|